A beta blocker typically used to treat heart problems, hemangioma, migraines and anxiety could be a new therapeutic for patients with sickle cell disease. Researchers led by Ankit A. Desai, MD, associate professor of medicine at the Krannert Cardiovascular Research Center (KCVRC) at Indiana University School of Medicine, have been awarded a $3 million grant by the U.S. Department of Defense to evaluate the efficacy of this drug.
More Salty Diets Linked to Higher Risk of Atopic Dermatitis
A higher level of daily sodium intake was associated with an increased risk of atopic dermatitis, a cross-sectional study suggested. In a cohort of over
June 6, 2024